REFERENCES
- Rigamonti C., Volta C., Colombi S., et al. Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion. Leukemia 2001; 15: 186–187
- Shah C., Grethlein S. J. Case report of rituximab-induced thrombocytopenia. Am. J. Hematol. 2004; 75: 263
- Pamuk G. E., Donmez S., Turgut B., et al. Rituximab-induced acute thrombocytopenia in a patient with prolymphocytic leukemia. Am. J. Hematol. 2005; 78: 81
- Otrock Z. K., Mahfouz R. A., Oghlakian G. O., et al. Rituximab-induced acute thrombocytopenia: a report of two cases. Haematologica 2005; 90(Suppl)ECR23
- Thachil J., Mukherje K., Woodcock B. Rituximab-induced haemorrhagic thrombocytopenia in a patient with hairy cell leukaemia. Br. J. Haematol 2006; 135(2)273–274
- Larrar S., Guitton C., Willems M., Bader-Meunier B. Severe hematological side effects following Rituximab therapy in children. Haematologica 2006; 91(8 Suppl)ECR36
- Maloney D. G., Grillo-Lopez A. J., White C. A., et al. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 1997; 90(6)2188–2195
- Winkler U., Jensen M., Manzke O., et al. Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8). Blood 1999; 94(7)2217–2224
- Byrd J. C., Waselenko J. K., Maneatis T. J., et al. Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: association with increased infusion-related side effects and rapid blood tumor clearance. J. Clin. Oncol. 1999; 17(3)791–795
- Kollmar O., Becker S., Schilling M. K., Maurer C. A. Intestinal lymphoma perforations as a consequence of highly effective anti-CD20 antibody therapy. Transplantation 2002; 73(4)669–670
- Jabr FI. Acute tumor lysis syndrome induced by rituximab in diffuse large B-cell lymphoma. Int. J. Hematol 2005; 82(4)312–314
- Enríquez E., Borrás-Blasco J., Sirvent A. E., et al. Early onset neutropenia after rituximab in lupus nephritis. Clin. Exp. Rheumatol 2007; 25(2)345
- Chaiwatanatorn K., Lee N., Grigg A., et al. Delayed-onset neutropenia associated with rituximab therapy. Br. J. Haematol 2003; 121(6)913–918